<DOC>
	<DOC>NCT02308501</DOC>
	<brief_summary>A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft Â® as Measured by In-Vivo Confocal Microscopy</brief_summary>
	<brief_title>A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<mesh_term>Alcaftadine</mesh_term>
	<criteria>Have a positive history of ocular allergies and a positive skin test to protocol defined allergens Have a positive CAC reaction at Visit 1 Have a positive conjunctival inflammation score at Visit 1 May not use disallowed medications in specified washout period May not have an ocular or system disease the investigator feels with impact subject safety or trial parameters May not have active ocular infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>